-
1
Relapse of Diffuse Large B‐Cell Lymphoma as Painless Masses in the Abdominal Wall Muscles: A Rare Case Report
Published 2025-01-01Subjects: Get full text
Article -
2
Myeloid-derived suppressor cells exhibit distinct characteristics in bone marrow and blood of individuals with diffuse large B-cell lymphoma
Published 2025-01-01Subjects: “…DLBCL…”
Get full text
Article -
3
Refining prognostic assessment of diffuse large B-cell lymphoma: insights from multi-omics and single-cell analysis unveil SRM as a key target for regulating immunotherapy
Published 2025-01-01Subjects: “…DLBCL…”
Get full text
Article -
4
Case report: From misdiagnosis to timely detection: a clinical and imaging guide to neurological presentations of diffuse large B-cell lymphoma—insights from six cases
Published 2025-02-01Subjects: “…DLBCL…”
Get full text
Article -
5
Circulating Free RNA as a Therapeutic Evaluation in Diffuse Large B-cell Lymphoma: A Case Series from the Indonesian Cancer Center
Published 2024-10-01Subjects: Get full text
Article -
6
Treatment of primary esophageal lymphomas: A review
Published 2025-02-01Subjects: Get full text
Article -
7
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
Published 2025-01-01Subjects: Get full text
Article -
8
Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levels
Published 2025-01-01Subjects: Get full text
Article -
9
Integrating multi‐omics features enables non‐invasive early diagnosis and treatment response prediction of diffuse large B‐cell lymphoma
Published 2025-01-01Subjects: Get full text
Article -
10
-
11
-
12
BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
Published 2025-01-01Subjects: Get full text
Article -
13
-
14
APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway
Published 2025-01-01Subjects: Get full text
Article -
15
CD20 Negative Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type with Rapidly Progressing Skin Lesions
Published 2023-09-01Subjects: “…diffuse large B-cell lymphoma, leg type (DLBCL-LT)…”
Get full text
Article